Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 18, 2024
Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancerKota Kawabata, Tsuyoshi Takahashi, Koji Tanaka, et al.
Cancer Science|May 18, 2007
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancerPing He, Tetsuji Naka, Satoshi Serada, et al.
Oncotarget|September 26, 2018
Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancerTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.
British Journal of Cancer|October 6, 2021
Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumoursTomo Ishida, Tsuyoshi Takahashi, Yukinori Kurokawa, et al.
Experimental Dermatology|April 19, 2012
Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblastsKanako Ontsuka, Yorihisa Kotobuki, Hiroshi Shiraishi, et al.
Oncotarget|October 22, 2021
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancerTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 30, 2021
Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosisMasahiro Koh, Tsuyoshi Takahashi, Yukinori Kurokawa, et al.
Oncotarget|April 28, 2017
Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinomaEmi Harada, Satoshi Serada, Minoru Fujimoto, et al.
American Journal of Obstetrics and Gynecology|August 22, 2020
CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcomaRuriko Nakae, Shinya Matsuzaki, Satoshi Serada, et al.
Anticancer Research|May 29, 2023
Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 AntibodyYurina Saito, Tsuyoshi Takahashi, Kosuke Hiramatsu, et al.
Pageof 13